Jump to content

Long Term Disease Control in Pancreatic Cancer


Recommended Posts

From Presswatch

Here's some good news about the use of those strange things Monoclonal Antibodies which seem to be the focus of some attention. Its merely a lab based study though its encouraging that tigatuzumab (DR5) seems to making an impact on Pancreatic Cancer by helping to control re-growth of cells ( cancer stem cell control)


The work seems to be based in John Hopkins (USA) though also involves Spannish contributions which is also encouraging.


Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.